-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB BIOTHERAPEUTICS INC : OPPENHEIMER INITIATES WITH OUTPERFORM RATING AND $12 TARGET PRICE

Reuters·08/28/2024 12:04:23

Please log in to view news